| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.GENE.2013.03.131 |
| P953 | full work available at URL | https://api.elsevier.com/content/article/PII:S0378111913004265?httpAccept=text/plain |
| https://api.elsevier.com/content/article/PII:S0378111913004265?httpAccept=text/xml | ||
| P698 | PubMed publication ID | 23583798 |
| P2093 | author name string | Yan Wang | |
| Qibing Mei | |||
| Naping Tang | |||
| P2860 | cites work | Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease | Q22337234 |
| Bias in meta-analysis detected by a simple, graphical test | Q24685585 | ||
| Quantifying heterogeneity in a meta-analysis | Q27860672 | ||
| Meta-analysis in clinical trials | Q27860779 | ||
| Statistical aspects of the analysis of data from retrospective studies of disease | Q27860916 | ||
| Nitric oxide is a physiological substrate for mammalian peroxidases | Q28645799 | ||
| Biosynthesis, processing, and sorting of human myeloperoxidase | Q33223927 | ||
| Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro | Q33852491 | ||
| Interpreting meta-analyses of genome-wide association studies | Q34187048 | ||
| Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions | Q34236265 | ||
| Genetics of Human Cardiovascular Disease | Q34261931 | ||
| Prognostic value of myeloperoxidase in patients with chest pain | Q34271813 | ||
| Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization | Q34448710 | ||
| Myeloperoxidase gene-463G > a polymorphism and premature coronary artery disease | Q34565544 | ||
| Reactive oxygen species in cardiovascular disease. | Q35165194 | ||
| Genetic basis of atherosclerosis: insights from mice and humans | Q35975437 | ||
| Systematic review and meta-analysis of the association between {beta}2-adrenoceptor polymorphisms and asthma: a HuGE review. | Q36178971 | ||
| Required sample size and nonreplicability thresholds for heterogeneous genetic associations | Q36392953 | ||
| The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport | Q37512515 | ||
| Myeloperoxidase: a useful biomarker for cardiovascular disease risk stratification? | Q37531578 | ||
| Meta-analysis of genetic association studies: methodologies, between-study heterogeneity and winner's curse | Q37620160 | ||
| Pathophysiology of atherosclerosis: the role of inflammation | Q37971961 | ||
| An Alu element in the myeloperoxidase promoter contains a composite SP1-thyroid hormone-retinoic acid response element | Q38356635 | ||
| Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population Study | Q40196845 | ||
| Biased tests of association: comparisons of allele frequencies when departing from Hardy-Weinberg proportions | Q43671466 | ||
| A method for meta-analysis of molecular association studies | Q45165474 | ||
| Death in the United States, 2009 | Q51379462 | ||
| Effects of myeloperoxidase -463 G/A gene polymorphism and plasma levels on coronary artery disease. | Q54423121 | ||
| Myeloperoxidase is associated with incident coronary heart disease independently of traditional risk factors: results from the MONICA/KORA Augsburg study | Q57414500 | ||
| Neutrophil myeloperoxidase activity and the influence of two single-nucleotide promoter polymorphisms | Q58451211 | ||
| Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes | Q73894487 | ||
| A functional myeloperoxidase polymorphic variant is associated with coronary artery disease in French-Canadians | Q74293599 | ||
| Analysis of multiple single nucleotide polymorphisms (SNPs) of myeloperoxidase (MPO) to screen for genetic markers associated with acute leukemia in Chinese Han population | Q80266059 | ||
| Heterogeneity testing in meta-analysis of genome searches | Q81128804 | ||
| The myeloperoxidase gene and its influence on myocardial infarction in a Swedish population: protective role of the -129A allele in women | Q84098150 | ||
| Elevated Serum Myeloperoxidase Activities are Significantly Associated with the Prevalence of ACS and High LDL-C Levels in CHD Patients | Q84280084 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | coronary artery disease | Q844935 |
| P304 | page(s) | 152-157 | |
| P577 | publication date | 2013-04-10 | |
| P1433 | published in | Gene | Q5531065 |
| P1476 | title | Myeloperoxidase G-463A polymorphism and susceptibility to coronary artery disease: a meta-analysis | |
| Myeloperoxidase G-463A polymorphism and susceptibility to coronary artery disease: A meta-analysis | |||
| P478 | volume | 523 |
| Q99630362 | Association between myeloperoxidase rs2333227 polymorphism and susceptibility to coronary heart disease |
| Q57292002 | Association of monocyte myeloperoxidase with incident cardiovascular disease: The Atherosclerosis Risk in Communities Study |
| Q59807449 | Chlorination and oxidation of the extracellular matrix protein laminin and basement membrane extracts by hypochlorous acid and myeloperoxidase |
| Q47142308 | Effects of MPO-463G/A and -129G/A polymorphisms on coronary artery disease risk and patient survival in a Turkish population |
| Q37727318 | PRISMA-combined Myeloperoxidase -463G/A gene polymorphism and coronary artery disease: A meta-analysis of 4744 subjects |
| Q39240889 | Relation of myeloperoxidase-463G/A polymorphism with metabolic syndrome and its component traits in Egyptian women |
| Q35702958 | Thiocyanate supplementation decreases atherosclerotic plaque in mice expressing human myeloperoxidase. |
Search more.